raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79241

Biotinidase deficiency

Synonyms: Juvenile-onset multiple carboxylase deficiency · Late-onset multiple carboxylase deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Adult, Childhood, Infancy, Neonatal
Status
active

A late-onset form of multiple carboxylase deficiency, an inborn error of biotin metabolism that, if untreated, is characterized by seizures, breathing difficulties, hypotonia, skin rash, alopecia, hearing loss and delayed development.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enBiotinidase deficiencyJuvenile-onset multiple carboxylase deficiency · Late-onset multiple carboxylase deficiency
frDéficit en biotinidaseDéficit multiple en carboxylases par déficit en biotinidase · Déficit multiple en carboxylases à début tardif
deBiotinidase-MangelBTD-Mangel · Multipler Carboxylase-Mangel, juveniler · Multipler Carboxylase-Mangel, spät-einsetzender
esDeficiencia de biotinidasaDeficiencia múltiple de carboxilasas de inicio juvenil · Deficiencia múltiple de carboxilasas de inicio tardío
itDeficit di biotinidasiDeficit di BTD · Deficit multiplo di carbossilasi a esordio giovanile · Deficit multiplo di carbossilasi a esordio tardivo
nlBiotinidasedeficiëntieMultipele carboxylasedeficiëntie met juveniele aanvang · Multipele carboxylasedeficiëntie met late aanvang
ptDeficiência de biotinidase
plNiedobór biotynidazyMłodzieńczy złożony Niedobór karboksylazy · Niedobór BTD · Złożony Niedobór karboksylazy o późnym początku
csDeficit biotinidázyDeficit BTD · Mnohočetný karboxylázový deficit s juvenilním začátkem · Mnohočetný karboxylázový deficit s pozdním začátkem
ukДефіцит біотинідазиЮвенільний дефіцит множинної карбоксилази · Пізній дефіцит множинної карбоксилази
zh生物素酶缺陷症幼年型多发性羧化酶缺乏
trBiyotinidaz eksikliğiBTD eksikliği · Geç başlangıçlı çoklu karboksilaz eksikliği · jüvenil başlangıçlı çoklu karboksilaz eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM253260Evalidated
ICD-10E53.8NTBTattributedvalidated
ICD-115C50.E0NTBTindexvalidated
MONDO0009665Evalidated
MeSHD028921Evalidated
UMLSC0220754Evalidated
GARD894Evalidated
MedDRA10071434Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
BTDDisease-causing germline mutation(s) inAssessedHGNC:1122ENSG000001698146090193p25.1biotinidase20301497[PMID]
5

Prevalence and incidence

13 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0001.6 / 100 000WorldwideValue and classNot yet validated1779651[PMID]
Point prevalence1-9 / 100 000—WorldwideClass onlyNot yet validated1779651[PMID]
Prevalence at birth1-9 / 100 0001.5 / 100 000United StatesValue and classValidated2314964[PMID]
Prevalence at birth1-9 / 100 0001.6 / 100 000BrazilValue and classValidated9713119[PMID]
Point prevalence1-9 / 100 0001.6 / 100 000EuropeValue and classValidated[EXPERT]
Prevalence at birth1-9 / 100 0002 / 100 000SwedenValue and classValidated20224900[PMID]
Prevalence at birth1-9 / 100 0003.2 / 100 000ItalyValue and classValidated11953730[PMID]_3391228[PMID]
Point prevalence1-9 / 100 000—ItalyClass onlyValidated11953730[PMID]_3391228[PMID]
Prevalence at birth1-9 / 100 0001.4 / 100 000AustriaValue and classValidated11388594[PMID]
Prevalence at birth1-9 / 100 0005 / 100 000HungaryValue and classValidated17185019[PMID]
Prevalence at birth1-9 / 100 0003 / 100 000TurkeyValue and classValidated20333870[PMID]
Point prevalence<1 / 1 000 0000.0069 / 100 000ChinaValue and classValidated34103049[PMID]
Prevalence at birth1-5 / 10 00011.58 / 100 000Czech RepublicValue and classValidated31241292[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

38 annotations · validated 2021-01-29
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0410145Decreased biotinidase activity
HP:0005979Metabolic ketoacidosis
HP:0001992Organic aciduria
Frequent (79-30%)
HP:0002715Abnormality of the immune system
HP:0000707Abnormality of the nervous system
HP:0410263Brain imaging abnormality
HP:0001987Hyperammonemia
HP:0001252Hypotonia
HP:0001250Seizure
HP:0000407Sensorineural hearing impairment
HP:0000988Skin rash
Occasional (29-5%)
HP:0000478Abnormality of the eye
HP:0001596Alopecia
HP:0002104Apnea
HP:0001251Ataxia
HP:0002069Bilateral tonic-clonic seizure
HP:0000509Conjunctivitis
HP:0000964Eczematoid dermatitis
HP:0011153Focal motor seizure
HP:0002123Generalized myoclonic seizure
HP:0001263Global developmental delay
HP:0000365Hearing impairment
HP:0002883Hyperventilation
HP:0012469Infantile spasms
HP:0001249Intellectual disability
HP:0006511Laryngeal stridor
HP:0001254Lethargy
HP:0003690Limb muscle weakness
HP:0002196Myelopathy
HP:0200068Nonprogressive visual loss
HP:0000648Optic atrophy
HP:0001138Optic neuropathy
HP:0005401Recurrent candida infections
HP:0002841Recurrent fungal infections
HP:0004429Recurrent viral infections
HP:0002098Respiratory distress
HP:0000575Scotoma
HP:0002313Spastic paraparesis

Run the differential on the 3 obligate / very frequent terms

Annotation source: 30746739[PMID]_20301497[PMID]

7

Sources for this card